Literature DB >> 4014502

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects.

R Brown, J H Kocsis, S Caroff, J Amsterdam, A Winokur, P E Stokes, A Frazer.   

Abstract

The authors took multiple serum samples for measurement of melatonin between 4:30 p.m. and 7:30 a.m. in seven male depressed patients with melancholia and five healthy male control subjects and found that melancholic patients had a significantly lower rise of melatonin. They also compared a second, separate group of 14 women and five men suffering from melancholic depression with seven healthy male control subjects and nine depressed women without melancholia. The melancholic patients had a significantly lower concentration of serum melatonin at 11:00 p.m. than either the control subjects or the nonmelancholic depressed patients. These findings support the possibility that the functioning of the pineal gland is altered in these patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014502     DOI: 10.1176/ajp.142.7.811

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

2.  Age, alcoholism and depression are associated with low levels of urinary melatonin.

Authors:  L Wetterberg; B Aperia; D A Gorelick; H E Gwirtzman; M T McGuire; E A Serafetinides; A Yuwiler
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

Review 3.  Current perspectives on the genetics of unipolar depression.

Authors:  S O Moldin; T Reich; J P Rice
Journal:  Behav Genet       Date:  1991-05       Impact factor: 2.805

4.  Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys.

Authors:  D L Murphy; N A Garrick; J L Hill; L Tamarkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 6.  Pineal melatonin and sensory symptoms in Parkinson disease.

Authors:  R Sandyk
Journal:  Ital J Neurol Sci       Date:  1989-08

Review 7.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

8.  Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.

Authors:  S H Kennedy; B A Davis; G M Brown; C G Ford; J d'Souza
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 9.  Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

Authors:  N P Nair; S K Ahmed; N M Kin
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

10.  Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.

Authors:  L von Knorring; B G Almay; J Häggendal; F Johansson; L Oreland; L Wetterberg
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.